Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young (Nasdaq: SY) reported unaudited Q3 2025 results on November 17, 2025. Total revenue was RMB386.7 million (US$54.3M), up 4.0% year‑over‑year. Aesthetic treatment services revenue rose to RMB183.6 million (US$25.8M), a 304.6% increase from Q3 2024 and above guidance.
The company operated 39 branded aesthetic centers at quarter end, with over 89,800 verified treatment visits and 194,700 treatments in the quarter. Active users exceeded 130,000. 20 centers reached profitability and 29 centers produced positive quarterly operating cash flow.
Q3 net loss attributable to So-Young was RMB64.3 million (US$9.0M); non-GAAP net loss was RMB61.6 million (US$8.7M). Cash and equivalents were RMB942.8 million. Guidance for Q4 2025 aesthetic treatment revenue is RMB216.0–226.0 million (165.8%–178.1% YoY increase).
So-Young (NASDAQ: SY) will report third quarter 2025 financial results for the period ended September 30, 2025 before U.S. markets open on November 17, 2025.
Management will host an earnings conference call on November 17, 2025 at 7:00 AM ET (8:00 PM Beijing/Hong Kong time). Telephone replay will be available from two hours after the call through 23:59 ET on November 24, 2025. A live and archived webcast will be available at http://ir.soyoung.com.
So-Young International Inc. (Nasdaq: SY), China's leading aesthetic treatment platform, reported Q2 2025 financial results showing mixed performance. Total revenues decreased 7.0% to RMB378.7 million (US$52.9 million) compared to Q2 2024. The company reported a net loss of RMB36.0 million (US$5.0 million), contrasting with a net income of RMB18.9 million in Q2 2024.
Notable highlights include aesthetic treatment services revenues surging 426.1% to RMB144.4 million, becoming the largest revenue contributor for the first time. The company now operates 29 branded aesthetic centers across nine major Chinese cities, with 25 centers achieving positive monthly operating cash flow. The number of verified treatment visits reached 67,400, with over 154,500 verified paid aesthetic treatments performed.
For Q3 2025, So-Young expects aesthetic treatment services revenues between RMB150.0-170.0 million, representing 230.5-274.6% year-over-year growth.
So-Young International Inc. (NASDAQ: SY), China's leading aesthetic treatment platform, reported Q2 2025 financial results with total revenues of RMB378.7 million (US$52.9 million), down 7.0% year-over-year. The company's aesthetic treatment services revenue surged 426.1% to RMB144.4 million, becoming the largest revenue contributor for the first time.
The company now operates 29 branded aesthetic centers across 9 major Chinese cities, with 25 centers achieving positive monthly operating cash flow. Key operational metrics showed significant growth, with verified treatment visits reaching 67,400 and active users exceeding 100,400. However, So-Young reported a net loss of RMB36.0 million, compared to a net income of RMB18.9 million in Q2 2024.
For Q3 2025, So-Young expects aesthetic treatment services revenues between RMB150.0-170.0 million, representing 230.5-274.6% year-over-year growth.
[ "Aesthetic treatment services revenue grew 426.1% year-over-year to RMB144.4 million", "25 out of 29 branded aesthetic centers achieved positive monthly operating cash flow", "Verified treatment visits increased significantly to 67,400 from 14,000 year-over-year", "Active users grew to 100,400 from 16,000 in the corresponding period", "Strong Q3 2025 guidance projecting 230.5-274.6% growth in aesthetic treatment services" ]So-Young International (NASDAQ: SY), China's leading aesthetic treatment platform, will release its Q2 2025 financial results on August 15, 2025, before U.S. markets open.
The company will host an earnings conference call on August 15, 2025, at 7:30 AM ET (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until August 22, 2025, and investors can also access the live and archived webcast through the company's investor relations website.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, has successfully regained compliance with Nasdaq's minimum bid price requirement. The company received confirmation from Nasdaq on July 2, 2025, after maintaining a closing bid price of $1.00 or higher for its American depositary shares (ADSs) for 10 consecutive business days from June 17 to July 1, 2025.
This development resolves the compliance issue that began on August 28, 2024, when So-Young was initially notified of non-compliance. The company had received two compliance periods: an initial 180-day period until February 24, 2025, followed by an extension until August 25, 2025. With this requirement now met, Nasdaq has closed the matter.
So-Young International Inc. (NASDAQ: SY), China's leading aesthetic treatment platform, has scheduled its first quarter 2025 financial results announcement for May 16, 2025, before U.S. markets open. The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 23, 2025, and interested parties can also access a live and archived webcast of the conference call through the company's investor relations website.
FAQ
What is the current stock price of So-Young Intl (SY)?
What is the market cap of So-Young Intl (SY)?
